BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 117179
Published online Jun 27, 2026. doi: 10.4240/wjgs.117179
Table 2 Comparison of primary and secondary clinical outcomes between groups, n (%)/mean ± SD
Outcome
Intervention group (n = 60)
Control group (n = 58)
t/χ2
P value
Incidence of UE2 (3.33)9 (15.52)0.028
Duration of mechanical ventilation (days)4.23 ± 1.626.14 ± 2.315.2140.000
Duration of stay in ICU (days)6.82 ± 2.119.34 ± 3.065.2230.000
Duration of delirium (days)2.12 ± 0.913.73 ± 1.417.3940.000
Composite post-reintubation complications0 (0.00)5 (8.62)0.026
Drug-related adverse events (total)15 (25.00)19 (32.76)0.8660.352


Write to the Help Desk